For decades, laser treatment for retinal diseases meant “photocoagulation”—a process that, while effective, often left behind permanent scars and tissue damage. However, a newer approach called Subthreshold Micropulse Laser (SML) is changing the landscape of eye care by offering a way to treat the retina without the collateral damage.
How It Works: The “Reset Theory”
Unlike traditional continuous-wave lasers that use heat to destroy tissue, SML delivers laser energy in short bursts (micropulses) followed by cooling intervals. This prevents the temperature from reaching a destructive “threshold,” avoiding visible retinal scarring.
Instead of burning the tissue, SML triggers a therapeutic cellular response known as the “Reset Theory”. The laser stimulates the retinal pigment epithelium (RPE) to produce heat shock proteins (HSP). These proteins act as molecular chaperones, helping damaged cells repair themselves and restoring normal retinal function—effectively “resetting” the biological environment of the eye.
Key Applications in Retinal Disease
SML has shown promise across several major eye conditions:
- Diabetic Macular Edema (DME): SML is particularly effective for patients with early-stage DME or those with a central retinal thickness of less than 400 μm. It can be used alongside anti-VEGF injections to significantly reduce the total number of shots a patient needs over time.
- Central Serous Chorioretinopathy (CSCR): SML is a valuable alternative to Photodynamic Therapy (PDT), especially during global medication shortages. It improves the RPE’s ability to “pump” out excess fluid from under the retina without causing laser-induced scars or atrophy.
- Age-Related Macular Degeneration (AMD): Emerging research suggests SML may help slow the progression of geographic atrophy (dry AMD) and can even “re-sensitize” patients with wet AMD to their anti-VEGF injections if they have stopped responding.
- Other Conditions: The therapy is also being used to treat macular edema following retinal vein occlusion (RVO) and complex cases like dome-shaped maculopathy and Coats disease.
Why Safety Matters
One of the most significant advantages of SML is its safety profile. Because it uses a low duty cycle (typically 5%, meaning the laser is only “on” for 5% of the treatment time), the risk of accidental burns is virtually eliminated. This allows doctors to treat areas very close to the fovea—the center of our vision—where traditional lasers would be too dangerous to use.
The Bottom Line
Subthreshold Micropulse Laser represents a shift from destructive surgery to regenerative therapy. While more large-scale studies are needed to standardize exactly which laser settings work best for every patient, SML currently offers a non-invasive, repeatable, and painless option for maintaining long-term vision health.
Reference
Sim, S. Y., Lim, L. T., Chaudhary, S., Musa, M., Hamilton, R., Nicholson, L., Pal, B., Saini, P., Mankongcharoen, P., & Sen, S. (2026). Update on subthreshold micropulse laser treatment for retinal diseases: A narrative review. Survey of Ophthalmology, 71(2026), 1044–1057.
